Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Document › Details

Bayer AG. (8/24/18). "Press Release: Bayer Secures Approval in the EU for Xarelto (rivaroxaban) for Patients with Coronary or Peripheral Artery Disease [Not intended for U.S. and UK Media]". Berlin.

Region Region EU (European Union)
Organisations Organisation Bayer AG
  Group Bayer (Group)
  Organisation 2 European Commission (EC)
  Group EU (govt)
Products Product Xarelto®
  Product 2 acetyl salicylic acid (INN s)
Person Person Möller, Jörg (Bayer 201403 Bayer HealthCare Head of Global Development)
     


   
Record changed: 2018-08-28

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Bayer (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top